Adept Therapeutics Inc. (AdeptTx) is an innovative start-up biotech company located at Beverly and Woburn in Great Boston area, MA, with passion and commitment to discover and develop potentially life-changing medicines for people with unmet medical needs. Focusing on T cells, Natural Killer cells and immune-suppressive myeloid cells, we leverage multiple advanced antibody technologies to discover fully human or humanized antibody therapeutics to enhance anti-tumor immunity. We are establishing and optimizing two unique platforms including immune cell engager bispecific antibodies and multi-functional tri-specific antibodies, which change tumor microenvironment (TME) to boost immune responses against cancer cells through 1) recruiting and activating effector immune cells and 2) modulating immune-suppressive TME to support tumor killing effector cell function. Our expertise in GPCR antibody discovery and development enable us to reach for the “high-hanging fruits”, the most challenging targets for antibody therapeutics discovery . Our broad product portfolio focuses on both hematological malignancies, such as cutaneous lymphoma, and solid tumors including triple negative breast cancer, ovarian, colon, kidney, renal，prostate, and pancreatic cancers etc.